Neurotech Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Neurotech Pharmaceuticals's estimated annual revenue is currently $14.9M per year.
- Neurotech Pharmaceuticals's estimated revenue per employee is $147,327
Employee Data
- Neurotech Pharmaceuticals has 101 Employees.
- Neurotech Pharmaceuticals grew their employee count by 31% last year.
Neurotech Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | Lecturer | Reveal Email/Phone |
Neurotech Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1M | 13 | -19% | N/A | N/A |
#2 | $0.8M | 5 | -29% | N/A | N/A |
#3 | $0.9M | 6 | 20% | N/A | N/A |
#4 | $0.8M | 5 | 0% | N/A | N/A |
#5 | $0.9M | 6 | -14% | N/A | N/A |
#6 | $0.7M | 4 | -43% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $1.9M | 12 | 0% | N/A | N/A |
#9 | $14.9M | 101 | 31% | N/A | N/A |
#10 | $1.4M | 9 | 0% | N/A | N/A |
What Is Neurotech Pharmaceuticals?
Neurotech Pharmaceuticals, Inc. is a privately held biotech company located in Cumberland, Rhode Island. Neurotech has spent years developing the science, technology, team and manufacturing behind NT-501. As a result of a unique partnership and clear direction, we are focused on bringing a long-term treatment to Macular Telangiectasia (MacTel) patients.Our team is focused on bringing to market this treatment designed to slow the progression of MacTel and the vision impairments it causes in patients who don't have another treatment option. Our goal is to help these patients sustain their quality of life.
keywords:N/AN/A
Total Funding
101
Number of Employees
$14.9M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $27.5M | 102 | -5% | N/A |
#2 | $29.3M | 116 | 2% | N/A |
#3 | $29.9M | 119 | -2% | N/A |
#4 | $40M | 138 | 7% | N/A |
#5 | $32.1M | 162 | 5% | N/A |